Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Tyme Inc. is a clinical-stage biotechnology company developing novel cancer therapeutics, intended to be safe and effective across a broad range of tumor types. We are led by an experienced management team and advised by a distinguished board of directors. Tyme continues to build strong institutional collaborations that include Mt. Sinai, the Mayo Clinic and many others.